| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |